Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

[1]  K. Godse,et al.  Topical corticosteroids in dermatology , 2016, Indian journal of dermatology, venereology and leprology.

[2]  H. Y. Lin,et al.  Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[3]  G. Yosipovitch,et al.  Cholinergic induction of perspiration attenuates nonhistaminergic pruritus in the skin of patients with atopic dermatitis and healthy controls , 2015, The British journal of dermatology.

[4]  G. Yosipovitch,et al.  Epidemiology of Chronic Pruritus: Where Have We Been and Where Are We Going? , 2015, Current Dermatology Reports.

[5]  V. Kinsler,et al.  The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring , 2015, Journal of the American Academy of Dermatology.

[6]  D. Stablein,et al.  Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy , 2015, Pediatrics.

[7]  S. Takeuchi,et al.  Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8 , 2014, The British journal of dermatology.

[8]  E. Carstens,et al.  Role of spinal bombesin-responsive neurons in nonhistaminergic itch. , 2014, Journal of neurophysiology.

[9]  J. Silverberg,et al.  Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States. , 2014, JAMA dermatology.

[10]  Robert C Coghill,et al.  Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. , 2014, Journal of neurophysiology.

[11]  H. Van Bever,et al.  The role of antiseptic agents in atopic dermatitis , 2014, Asia Pacific allergy.

[12]  Alexandru D. P. Papoiu,et al.  Butorphanol Suppression of Histamine Itch is Mediated by Nucleus Accumbens and Septal Nuclei , 2014, The Journal of investigative dermatology.

[13]  M. Wittmann,et al.  Cytokines as therapeutic targets in skin inflammation. , 2014, Cytokine & growth factor reviews.

[14]  R. Gibson,et al.  A Randomised Trial Evaluating the Effects of the TRPV1 Antagonist SB705498 on Pruritus Induced by Histamine, and Cowhage Challenge in Healthy Volunteers , 2014, PloS one.

[15]  J. Wal,et al.  Cutaneous or Respiratory Exposures to Peanut Allergens in Mice and Their Impacts on Subsequent Oral Exposure , 2014, International Archives of Allergy and Immunology.

[16]  T. Bieber,et al.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. , 2014, The New England journal of medicine.

[17]  H. Nakagawa,et al.  Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial , 2014, The Journal of dermatology.

[18]  U. Beuers,et al.  Receptors, cells and circuits involved in pruritus of systemic disorders. , 2014, Biochimica et biophysica acta.

[19]  Bin Chen,et al.  The Histamine H4 Receptor Antagonist, JNJ 39758979, Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[20]  Xinzhong Dong,et al.  Itch mechanisms and circuits. , 2014, Annual review of biophysics.

[21]  T. Tüting,et al.  Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate‐induced mouse atopic‐like dermatitis , 2014, Experimental dermatology.

[22]  A. Morita,et al.  Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis. , 2014, Journal of dermatological science.

[23]  D. Rizopoulos,et al.  The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial. , 2014, Journal of the American Academy of Dermatology.

[24]  M. Kubo,et al.  Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. , 2014, The Journal of allergy and clinical immunology.

[25]  R. Tamagawa‐Mineoka,et al.  Increased serum levels of interleukin 33 in patients with atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.

[26]  T. Bíró,et al.  TRP channels in the skin , 2014, British journal of pharmacology.

[27]  B. Rosen,et al.  The brain circuitry mediating antipruritic effects of acupuncture. , 2014, Cerebral cortex.

[28]  C. Lynde,et al.  A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis. , 2014, Cutis.

[29]  Xinzhong Dong,et al.  Mrgprs as Itch Receptors , 2014 .

[30]  A. Gonzales,et al.  Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy , 2014, Journal of veterinary pharmacology and therapeutics.

[31]  J. Schmitt,et al.  Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. , 2014, The Journal of allergy and clinical immunology.

[32]  T. Buhl,et al.  A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. , 2014, The Journal of allergy and clinical immunology.

[33]  Zhou-Feng Chen,et al.  B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway , 2014, Molecular pain.

[34]  J. Thierry-Mieg,et al.  Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia, and the spinal cord , 2014, Molecular pain.

[35]  M. Maurer,et al.  Interleukin‐31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge , 2014, Allergy.

[36]  H. Lou,et al.  TRPA1-Dependent Pruritus in IL-13–Induced Chronic Atopic Dermatitis , 2013, The Journal of Immunology.

[37]  G. Yosipovitch,et al.  IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. , 2013, The Journal of investigative dermatology.

[38]  R. Baba,et al.  Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia , 2013, The Journal of dermatology.

[39]  M. Pellegrino,et al.  The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch , 2013, Cell.

[40]  Alexandru D. P. Papoiu,et al.  A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch. , 2013, Acta dermato-venereologica.

[41]  T. Tüting,et al.  Anti‐inflammatory activity of topical THC in DNFB‐mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors , 2013, Allergy.

[42]  Harold Kim,et al.  CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults , 2013, Allergy, Asthma & Clinical Immunology.

[43]  William Abramovits,et al.  Pathways to managing atopic dermatitis: consensus from the experts. , 2013, The Journal of clinical and aesthetic dermatology.

[44]  M. Sugaya,et al.  Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis. , 2013, The Journal of investigative dermatology.

[45]  T. Werfel,et al.  Interleukin (IL)‐31 activates signal transducer and activator of transcription (STAT)‐1, STAT‐5 and extracellular signal‐regulated kinase 1/2 and down‐regulates IL‐12p40 production in activated human macrophages , 2013, Allergy.

[46]  E. Lumpkin,et al.  The Ion Channel TRPA1 Is Required for Chronic Itch , 2013, The Journal of Neuroscience.

[47]  S. Mishra,et al.  The Cells and Circuitry for Itch Responses in Mice , 2013, Science.

[48]  J. C. Jaworski,et al.  Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice , 2013, American Journal of Clinical Dermatology.

[49]  Gil Yosipovitch,et al.  Skin pH: from basic science to basic skin care. , 2013, Acta dermato-venereologica.

[50]  C. Cockerell,et al.  Novel Sodium Hypochlorite Cleanser Shows Clinical Response and Excellent Acceptability in the Treatment of Atopic Dermatitis , 2013, Pediatric dermatology.

[51]  Alexandru D. P. Papoiu,et al.  Over-Expression of the Gastrin-Releasing Peptide in Cutaneous Nerve Fibers and its Receptor in Spinal Cord in Primates with Chronic Itch , 2013, The Journal of investigative dermatology.

[52]  A. Gottlieb,et al.  Phosphodiesterase 4-targeted treatments for autoimmune diseases , 2013, BMC Medicine.

[53]  E. Simpson,et al.  The effects of treatment on itch in atopic dermatitis , 2013, Dermatologic therapy.

[54]  G. Vianale,et al.  Cytokines and T cells in atopic dermatitis. , 2013, European cytokine network.

[55]  Seung Hun Lee,et al.  Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice. , 2013, The American journal of pathology.

[56]  M. El-Khalawany,et al.  Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt , 2013, European Journal of Pediatrics.

[57]  J. Szepietowski,et al.  Relationship between itch and psychological status of patients with atopic dermatitis , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[58]  G. Yosipovitch,et al.  Transient receptor potential channels and dermatological disorders. , 2013, Current topics in medicinal chemistry.

[59]  A. Hovnanian.  Netherton syndrome: skin inflammation and allergy by loss of protease inhibition , 2013, Cell and Tissue Research.

[60]  Y. Tada,et al.  Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosis , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[61]  Yiyuan Cui,et al.  A subpopulation of nociceptors specifically linked to itch , 2012, Nature Neuroscience.

[62]  A. Thompson,et al.  A meta‐analysis of the effectiveness of psychological interventions for adults with skin conditions , 2012, The British journal of dermatology.

[63]  Judith Nebus,et al.  Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy , 2012, Dermatology research and practice.

[64]  Jung Hyun Han,et al.  Topical TRPM8 agonist (icilin) relieved vulva pruritus originating from lichen sclerosus et atrophicus. , 2012, Acta dermato-venereologica.

[65]  A. Fleischer,et al.  Relieving the pruritus of atopic dermatitis: a meta-analysis. , 2012, Acta dermato-venereologica.

[66]  Soojin Lee,et al.  Atopic dermatitis and cytokines: recent patents in immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part I: cytokines in atopic dermatitis. , 2012, Recent patents on inflammation & allergy drug discovery.

[67]  D. Cruser,et al.  Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis , 2012, Dermatology research and practice.

[68]  E. Simpson,et al.  A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. , 2012, Archives of dermatology.

[69]  J. Fowler,et al.  Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis. , 2012, Journal of drugs in dermatology : JDD.

[70]  H. Tey,et al.  Atopic Dermatitis in African American Children: Addressing Unmet Needs of a Common Disease , 2012, Pediatric dermatology.

[71]  Xinzhong Dong,et al.  TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. , 2012, The Journal of clinical investigation.

[72]  H. Mizuno,et al.  Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. , 2012, The Journal of allergy and clinical immunology.

[73]  T. Reunala,et al.  IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. , 2012, The Journal of investigative dermatology.

[74]  M. Lóden.  Effect of moisturizers on epidermal barrier function. , 2012, Clinics in dermatology.

[75]  Y. Tada,et al.  Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. , 2012, Acta dermato-venereologica.

[76]  V. Napadow,et al.  Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis – a patient‐ and examiner‐blinded, randomized, placebo‐controlled, crossover trial , 2012, Allergy.

[77]  Xinzhong Dong,et al.  Peripheral mechanisms of itch , 2012, Neuroscience Bulletin.

[78]  A. Feily,et al.  Oatmeal in dermatology: a brief review. , 2012, Indian journal of dermatology, venereology and leprology.

[79]  Hui Wang,et al.  A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch , 2012, NeuroImage.

[80]  B. Lüscher,et al.  IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. , 2012, The Journal of allergy and clinical immunology.

[81]  J. Baurain,et al.  A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients , 2012, Dermatology research and practice.

[82]  B. Undem,et al.  Basic mechanisms of itch , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[83]  M. Steinhoff,et al.  Distribution and Expression of Non-Neuronal Transient Receptor Potential (TRPV) Ion Channels in Rosacea , 2011, The Journal of investigative dermatology.

[84]  S. Brain,et al.  Neurovascular aspects of skin neurogenic inflammation. , 2011, The journal of investigative dermatology. Symposium proceedings.

[85]  F. Simons,et al.  Histamine and H1-antihistamines: celebrating a century of progress. , 2011, The Journal of allergy and clinical immunology.

[86]  Alexandru D. P. Papoiu,et al.  A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects , 2011, Neuropeptides.

[87]  S. Jariwala,et al.  The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[88]  R. Meyer,et al.  A Role for Nociceptive, Myelinated Nerve Fibers in Itch Sensation , 2011, The Journal of Neuroscience.

[89]  Jung-Bum Lee,et al.  Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice , 2011, Peptides.

[90]  H. Ogawa,et al.  Matrix metalloproteinase-8 is involved in dermal nerve growth: implications for possible application to pruritus from in vitro models. , 2011, The Journal of investigative dermatology.

[91]  U. Sivaprasad,et al.  Th2 Cytokines and Atopic Dermatitis. , 2011, Journal of clinical & cellular immunology.

[92]  J. Schmitt,et al.  A randomized trial of methotrexate versus azathioprine for severe atopic eczema. , 2011, The Journal of allergy and clinical immunology.

[93]  T. Bíró,et al.  Transient receptor potential channels as therapeutic targets , 2011, Nature Reviews Drug Discovery.

[94]  Wendy M. Knowlton,et al.  Scraping through the ice: uncovering the role of TRPM8 in cold transduction. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[95]  M. Steinhoff,et al.  Management of itch in atopic dermatitis. , 2011, Seminars in cutaneous medicine and surgery.

[96]  E. Lerner,et al.  Topical therapies for pruritus. , 2011, Seminars in cutaneous medicine and surgery.

[97]  M. D. de Bruin‐Weller,et al.  Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. , 2011, Journal of the American Academy of Dermatology.

[98]  R. LaMotte,et al.  BAM8–22 Peptide Produces Itch and Nociceptive Sensations in Humans Independent of Histamine Release , 2011, The Journal of Neuroscience.

[99]  A. Patapoutian,et al.  Scratching the surface: a role of pain-sensing TRPA1 in itch , 2011, Nature Neuroscience.

[100]  K. Takamori,et al.  Erratum to “Topical application of emollients prevents dry skin-inducible intraepidermal nerve growth in acetone-treated mice” [J. Dermatol. Sci. 62 (2011) 64–66] , 2011 .

[101]  Xinzhong Dong,et al.  TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch , 2011, Nature Neuroscience.

[102]  K. Takamori,et al.  Topical application of emollients prevents dry skin-inducible intraepidermal nerve growth in acetone-treated mice. , 2011, Journal of dermatological science.

[103]  T. Luger,et al.  Itch in atopic dermatitis - pathophysiology and treatment. , 2010, Acta dermatovenerologica Croatica : ADC.

[104]  A. Hovnanian,et al.  Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. , 2010, The Journal of investigative dermatology.

[105]  S. Ziegler.  The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. , 2010, Current opinion in immunology.

[106]  I. Park,et al.  Association of stress with symptoms of atopic dermatitis. , 2010, Acta dermato-venereologica.

[107]  Moe Tsutsumi,et al.  Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold‐sensitive TRP receptors in epidermal permeability barrier homoeostasis , 2010, Experimental dermatology.

[108]  L. Eichenfield,et al.  The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis , 2010, Pediatric dermatology.

[109]  D. Kendall,et al.  Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. , 2010, Immunobiology.

[110]  B. Vincenzi,et al.  Aprepitant for erlotinib-induced pruritus. , 2010, The New England journal of medicine.

[111]  M. Denda,et al.  Topical application of TRPA1 agonists and brief cold exposure accelerate skin permeability barrier recovery. , 2010, The Journal of investigative dermatology.

[112]  B. Vincenzi,et al.  Aprepitant against pruritus in patients with solid tumours , 2010, Supportive Care in Cancer.

[113]  T. Luger,et al.  Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy , 2010, PloS one.

[114]  Alexandru D. P. Papoiu,et al.  Topical capsaicin. The fire of a ‘hot’ medicine is reignited , 2010, Expert opinion on pharmacotherapy.

[115]  R. LaMotte,et al.  Cathepsin S elicits itch and signals via protease-activated receptors. , 2010, The Journal of investigative dermatology.

[116]  S. Ständer,et al.  Increased levels of serum IL‐31 in chronic spontaneous urticaria * , 2010, Experimental dermatology.

[117]  Michael R Dores,et al.  Signal transduction by protease‐activated receptors , 2010, British journal of pharmacology.

[118]  S. Ziegler,et al.  Sensing the outside world: TSLP regulates barrier immunity , 2010, Nature Immunology.

[119]  G. Nilsson,et al.  Role of mast cells and sensory nerves in skin inflammation. , 2010, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[120]  R. Thurmond,et al.  The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. , 2010, The Journal of investigative dermatology.

[121]  R. Locksley,et al.  Asthma and Allergic Inflammation , 2010, Cell.

[122]  K. Schäkel,et al.  Prednisolone vs. ciclosporin for severe adult eczema. An investigator‐initiated double‐blind placebo‐controlled multicentre trial , 2010, The British journal of dermatology.

[123]  W. Leonard,et al.  Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin , 2010, PloS one.

[124]  M. Schmelz,et al.  Patterns of activity-dependent conduction velocity changes differentiate classes of unmyelinated mechano-insensitive afferents including cold nociceptors, in pig and in human , 2010, PAIN.

[125]  R. Geha,et al.  Thymic stromal lymphopoietin , 2010, Annals of the New York Academy of Sciences.

[126]  S. Feldman,et al.  Physicians' perceptions of an eczema action plan for atopic dermatitis , 2010, The Journal of dermatological treatment.

[127]  T. Mcclanahan,et al.  IL-33 Induces IL-13–Dependent Cutaneous Fibrosis , 2009, The Journal of Immunology.

[128]  David J. Anderson,et al.  Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus , 2009, Cell.

[129]  D. Irnich,et al.  Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema – a blinded, randomized, placebo‐controlled, crossover trial , 2009, Allergy.

[130]  L. Dubertret,et al.  Aprepitant as an antipruritic agent? , 2009, The New England journal of medicine.

[131]  J. Weinberg,et al.  AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. , 2009, Current opinion in investigational drugs.

[132]  R. Kraft,et al.  Distinct patterns of brain activity evoked by histamine‐induced itch reveal an association with itch intensity and disease severity in atopic dermatitis , 2009, The British journal of dermatology.

[133]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[134]  R. Locksley,et al.  IL‐18 and IL‐33 elicit Th2 cytokines from basophils via a MyD88‐ and p38α‐dependent pathway , 2009, Journal of leukocyte biology.

[135]  M. Ohtsuki,et al.  Guidelines for management of atopic dermatitis , 2009, The Journal of dermatology.

[136]  Zhou-Feng Chen,et al.  Cellular Basis of Itch Sensation , 2009, Science.

[137]  D. Shander,et al.  Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. , 2009, The Journal of investigative dermatology.

[138]  G. Godlewski,et al.  Receptors for acylethanolamides-GPR55 and GPR119. , 2009, Prostaglandins & other lipid mediators.

[139]  Jonathan Hadgraft,et al.  Epidermal barrier dysfunction in atopic dermatitis. , 2009, The Journal of investigative dermatology.

[140]  J. Szepietowski,et al.  Cannabinoid system in the skin – a possible target for future therapies in dermatology , 2009, Experimental dermatology.

[141]  H. Kita,et al.  Proteases Induce Production of Thymic Stromal Lymphopoietin by Airway Epithelial Cells through Protease-Activated Receptor-21 , 2009, The Journal of Immunology.

[142]  F. Liew,et al.  The cytokine interleukin-33 mediates anaphylactic shock , 2009, Proceedings of the National Academy of Sciences.

[143]  P. Dubus,et al.  Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome , 2009, The Journal of experimental medicine.

[144]  Steve Davidson,et al.  Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons , 2009, Nature Neuroscience.

[145]  A. Rademaker,et al.  Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity , 2009, Pediatrics.

[146]  T. Tötterman,et al.  Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour mass. , 2009, Scandinavian journal of haematology.

[147]  K. R. Maples,et al.  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. , 2009, Bioorganic & medicinal chemistry letters.

[148]  D. Corey,et al.  TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons , 2009, The Journal of Neuroscience.

[149]  W. Kirch,et al.  Outpatient care and medical treatment of children and adults with atopic eczema , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[150]  J. Schroeder,et al.  Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. , 2009, The Journal of investigative dermatology.

[151]  N. Undre,et al.  Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis , 2009, The British journal of dermatology.

[152]  Alexandru D. P. Papoiu,et al.  Itch characteristics in atopic dermatitis: results of a web‐based questionnaire , 2009, The British journal of dermatology.

[153]  F. Camacho,et al.  A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients , 2009, The Journal of dermatological treatment.

[154]  H. Stark,et al.  Histamine H4 receptor antagonism reduces hapten‐induced scratching behaviour but not inflammation , 2009, Experimental dermatology.

[155]  M. Sebastian,et al.  Proactive disease management with 0·03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study , 2008, The British journal of dermatology.

[156]  C. Baudouin,et al.  New Emollient with Topical Corticosteroid‐Sparing Effect in Treatment of Childhood Atopic Dermatitis: SCORAD and Quality of Life Improvement , 2008, Pediatric dermatology.

[157]  J. Szepietowski,et al.  Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[158]  Alexandru D. P. Papoiu,et al.  What causes itch in atopic dermatitis? , 2008, Current allergy and asthma reports.

[159]  S. Feldman,et al.  Written action plans: potential for improving outcomes in children with atopic dermatitis. , 2008, Journal of the American Academy of Dermatology.

[160]  Barbara Namer,et al.  Separate peripheral pathways for pruritus in man. , 2008, Journal of neurophysiology.

[161]  S. Ständer,et al.  Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[162]  C. Kirkpatrick,et al.  Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans , 2008, British journal of pharmacology.

[163]  L. Juliano,et al.  Evidence for the role of neurogenic inflammation components in trypsin‐elicited scratching behaviour in mice , 2008, British journal of pharmacology.

[164]  T. Luger,et al.  Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. , 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[165]  T. Arinami,et al.  Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case–control study , 2008, Journal of Human Genetics.

[166]  M. Southall,et al.  Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity , 2008, Archives of Dermatological Research.

[167]  Robert H. LaMotte,et al.  Cowhage-Evoked Itch Is Mediated by a Novel Cysteine Protease: A Ligand of Protease-Activated Receptors , 2008, The Journal of Neuroscience.

[168]  U. Gieler,et al.  [Atopic dermatitis and stress? How do emotions come into skin?]. , 2008, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[169]  E. Azmitia,et al.  The skin as a mirror of the soul: exploring the possible roles of serotonin , 2008, Experimental dermatology.

[170]  U. Gieler,et al.  Neurodermitis und Stress , 2008, Der Hautarzt.

[171]  S. Ständer,et al.  Neurophysiological and neurochemical basis of modern pruritus treatment , 2008, Experimental dermatology.

[172]  S. Hendrix,et al.  Skin and hair follicle innervation in experimental models: a guide for the exact and reproducible evaluation of neuronal plasticity , 2008, Experimental dermatology.

[173]  Z. Draelos.  Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas , 2008, Current medical research and opinion.

[174]  S. Chimenti,et al.  Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. , 2008, Photomedicine and laser surgery.

[175]  K. Takamori,et al.  Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. , 2007, Journal of dermatological science.

[176]  G. Yosipovitch,et al.  Menthol: a refreshing look at this ancient compound. , 2007, Journal of the American Academy of Dermatology.

[177]  D. Vetter,et al.  Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. , 2007, Experimental cell research.

[178]  Steve Davidson,et al.  The Itch-Producing Agents Histamine and Cowhage Activate Separate Populations of Primate Spinothalamic Tract Neurons , 2007, The Journal of Neuroscience.

[179]  J. Salomon,et al.  The role of selected neuropeptides in pathogenesis of atopic dermatitis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[180]  Yan-Gang Sun,et al.  A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.

[181]  R. Paus,et al.  TRP channels as novel players in the pathogenesis and therapy of itch. , 2007, Biochimica et biophysica acta.

[182]  G. Yosipovitch.  The pruritus receptor unit: a target for novel therapies. , 2007, The Journal of investigative dermatology.

[183]  P. Arck,et al.  From the Brain-Skin Connection: The Neuroendocrine-Immune Misalliance of Stress and Itch , 2007, Neuroimmunomodulation.

[184]  Matthias Ringkamp,et al.  Psychophysical and Physiological Evidence for Parallel Afferent Pathways Mediating the Sensation of Itch , 2007, The Journal of Neuroscience.

[185]  J. Ring,et al.  Adjuvant treatment of atopic eczema: assessment of an emollient containing N‐palmitoylethanolamine (ATOPA study) , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[186]  H. van Os-Medendorp,et al.  The nursing programme 'Coping with itch': a promising intervention for patients with chronic pruritic skin diseases. , 2007, Journal of clinical nursing.

[187]  M. Jafferany.  Psychodermatology: a guide to understanding common psychocutaneous disorders. , 2007, Primary care companion to the Journal of clinical psychiatry.

[188]  S. Werner,et al.  Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System , 2007, Science.

[189]  J. Changeux,et al.  The role of nicotinic receptors in B-lymphocyte development and activation. , 2007, Life sciences.

[190]  J. Schmitt,et al.  Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[191]  Misook Kim,et al.  TRPV1 Mediates Histamine-Induced Itching via the Activation of Phospholipase A2 and 12-Lipoxygenase , 2007, The Journal of Neuroscience.

[192]  M. Kietzmann,et al.  Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. , 2007, Inflammation & allergy drug targets.

[193]  W. Wallo,et al.  Colloidal oatmeal: history, chemistry and clinical properties. , 2007, Journal of drugs in dermatology : JDD.

[194]  G. Scott,et al.  Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year , 2007, The Journal of dermatological treatment.

[195]  R. Grimalt,et al.  The Steroid-Sparing Effect of an Emollient Therapy in Infants with Atopic Dermatitis: A Randomized Controlled Study , 2006, Dermatology.

[196]  M. Simon,et al.  Phospholipase Cβ 3 Mediates the Scratching Response Activated by the Histamine H1 Receptor on C-Fiber Nociceptive Neurons , 2006, Neuron.

[197]  T. Theoharides,et al.  The Critical Role of Mast Cells in Allergy and Inflammation , 2006, Annals of the New York Academy of Sciences.

[198]  R. Grimalt,et al.  Treatment of patients with atopic dermatitis using wet‐wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[199]  T. H. Clayton,et al.  The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy , 2006, Clinical and experimental dermatology.

[200]  D. Alexandrescu,et al.  Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine‐kinase inhibitors , 2006, Clinical and experimental dermatology.

[201]  R. Paus,et al.  Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. , 2006, The Journal of investigative dermatology.

[202]  T. Luger,et al.  [Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[203]  J. Taverna,et al.  Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. , 2006, Journal of the American Academy of Dermatology.

[204]  M. Pittelkow,et al.  Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. , 2006, The Journal of investigative dermatology.

[205]  M. Steinhoff,et al.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. , 2006, The Journal of investigative dermatology.

[206]  A. Muraro,et al.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. , 2006, The Journal of allergy and clinical immunology.

[207]  L. Kemény,et al.  Treatment of atopic dermatitis with the xenon chloride excimer laser , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[208]  M. Steinhoff,et al.  The neurobiology of itch , 2006, Nature Reviews Neuroscience.

[209]  H. Yu,et al.  Transepidermal water loss, serum IgE and β‐endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis , 2006, The British journal of dermatology.

[210]  T. Luger,et al.  Treatment of pruritic diseases with topical calcineurin inhibitors , 2006, Therapeutics and clinical risk management.

[211]  T. Sugiura,et al.  Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. , 2006, European journal of pharmacology.

[212]  A. Gottlieb,et al.  Benefits of mild cleansing: synthetic surfactant based (syndet) bars for patients with atopic dermatitis. , 2006, Cutis.

[213]  O. Johansson,et al.  Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study , 2006, Archives of Dermatological Research.

[214]  A. Devillers,et al.  Efficacy and safety of ‘wet‐wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature , 2006, The British journal of dermatology.

[215]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[216]  N. Reynolds,et al.  Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial , 2006, The Lancet.

[217]  G. Yosipovitch,et al.  Butorphanol for treatment of intractable pruritus. , 2006, Journal of the American Academy of Dermatology.

[218]  H. Renz,et al.  Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. , 2006, The Journal of allergy and clinical immunology.

[219]  B. L. Andersen,et al.  Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial , 2006, Allergy.

[220]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin: master switch for allergic inflammation , 2006, The Journal of experimental medicine.

[221]  C. Sheen,et al.  Neuropeptides activate human mast cell degranulation and chemokine production. , 2006, Immunology.

[222]  M. Steinhoff,et al.  IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[223]  M. Lakhanpaul,et al.  Low systemic exposure in infants with atopic dermatitis in a 1‐year pharmacokinetic study with pimecrolimus cream 1% * , 2006, Experimental dermatology.

[224]  S. Feldman,et al.  Adherence in dermatology: A review of the last 20 years , 2006, The Journal of dermatological treatment.

[225]  H. Kilbinger,et al.  In vivo release of non‐neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin , 2006, British journal of pharmacology.

[226]  Yi Dai,et al.  Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with aδ/c‐fibers and colocalization with trk receptors , 2005, The Journal of comparative neurology.

[227]  M. Kietzmann,et al.  The phosphodiesterase 4 inhibitor AWD 12–281 is active in a new guinea‐pig model of allergic skin inflammation predictive of human skin penetration and suppresses both Th1 and Th2 cytokines in mice , 2005, The Journal of pharmacy and pharmacology.

[228]  J. Ring,et al.  Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial. , 2005, The Journal of allergy and clinical immunology.

[229]  Valentin A. Pavlov,et al.  The cholinergic anti-inflammatory pathway , 2005, Brain, Behavior, and Immunity.

[230]  P. Chambon,et al.  Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[231]  M. Boguniewicz,et al.  Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study , 2005, Pediatrics.

[232]  V. Rogiers,et al.  Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. , 2005, The Journal of investigative dermatology.

[233]  S. Ziegler,et al.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.

[234]  J. Wess,et al.  Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway , 2005, Journal of Neuroimmunology.

[235]  Henry W. Lim,et al.  Ultraviolet phototherapy for pruritus , 2005, Dermatologic therapy.

[236]  Rajesh Balkrishnan,et al.  The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. , 2005, Medical care.

[237]  M. Boguniewicz.  Atopic dermatitis: beyond the itch that rashes. , 2005, Immunology and allergy clinics of North America.

[238]  S. Mulvihill,et al.  Transient Receptor Potential Vanilloid (TRPV-1) Promotes Neurogenic Inflammation in the Pancreas Via Activation of the Neurokinin-1 Receptor (NK-1R) , 2005, Pancreas.

[239]  S. Hunt,et al.  Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition , 2005, Journal of Molecular Medicine.

[240]  J. Kiecolt-Glaser,et al.  Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.

[241]  C. Müller-Goymann,et al.  An attempt to clarify the influence of glycerol, propylene glycol, isopropyl myristate and a combination of propylene glycol and isopropyl myristate on human stratum corneum. , 2005, Die Pharmazie.

[242]  H. Williams,et al.  The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. , 2004, Archives of dermatology.

[243]  E. Senba,et al.  The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers , 2004, Neuroscience Research.

[244]  S. Spector,et al.  Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[245]  J. Hanifin.  Atopic dermatitis: broadening the perspective. , 2004, Journal of the American Academy of Dermatology.

[246]  Jerry Tan,et al.  Safety and Efficacy of Tacrolimus Ointment 0.1% (Protopic™) in Atopic Dermatitis: A Canadian Open-Label Multicenter Study , 2004, Journal of cutaneous medicine and surgery.

[247]  Scott R. Presnell,et al.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.

[248]  I. Elenkov.  Glucocorticoids and the Th1/Th2 Balance , 2004, Annals of the New York Academy of Sciences.

[249]  G. Yosipovitch,et al.  Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. , 2004, Journal of the American Academy of Dermatology.

[250]  H. Simon,et al.  Eosinophils and atopic dermatitis , 2004, Allergy.

[251]  M. Criado,et al.  Glucocorticoid activation of the neuronal nicotinic acetylcholine receptor α7 subunit gene: involvement of transcription factor Egr‐1 , 2004, FEBS letters.

[252]  P. Conti,et al.  Mast cells: the Jekyll and Hyde of tumor growth. , 2004, Trends in immunology.

[253]  N. Martinelli,et al.  Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[254]  Johanne Sundby,et al.  Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. , 2004, The journal of investigative dermatology. Symposium proceedings.

[255]  M. Schumacher,et al.  Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures , 2004, Experimental dermatology.

[256]  Donald Y M Leung,et al.  Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .

[257]  A. Rawlings,et al.  Moisturization and skin barrier function , 2004, Dermatologic therapy.

[258]  A. Ny,et al.  Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme. , 2003, Acta dermato-venereologica.

[259]  Thomas A Luger,et al.  Consensus conference on pediatric atopic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[260]  D.Y. Lee,et al.  Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT‐PCR , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[261]  A. Paller,et al.  Atopic dermatitis and the atopic march. , 2003, The Journal of allergy and clinical immunology.

[262]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[263]  Sonja Ständer,et al.  Modern aspects of cutaneous neurogenic inflammation. , 2003, Archives of dermatology.

[264]  J. Sturchio,et al.  What information do patients need about medicines? , 2003, BMJ : British Medical Journal.

[265]  G. Elwyn,et al.  “Doing prescribing”: how doctors can be more effective , 2003, BMJ : British Medical Journal.

[266]  Rajesh Balkrishnan,et al.  Electronic monitoring of medication adherence in skin disease: results of a pilot study. , 2003, Journal of the American Academy of Dermatology.

[267]  H. Nagase,et al.  Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system , 2003 .

[268]  Shinichi Watanabe,et al.  Histamine enhances the production of nerve growth factor in human keratinocytes. , 2003, The Journal of investigative dermatology.

[269]  M. Cork,et al.  Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse , 2003, The British journal of dermatology.

[270]  M. D'Andrea,et al.  Proteinase-activated receptors: novel signals for peripheral nerves , 2003, Trends in Neurosciences.

[271]  A. Kraneveld,et al.  Functional Expression of Neurokinin 1 Receptors on Mast Cells Induced by IL-4 and Stem Cell Factor1 , 2003, The Journal of Immunology.

[272]  David J. Anderson,et al.  Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[273]  M. Kietzmann,et al.  AWD 12–281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis , 2003, The Journal of pharmacy and pharmacology.

[274]  Kenneth R Feingold,et al.  pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. , 2003, The Journal of investigative dermatology.

[275]  M. Lóden.  Do moisturizers work? , 2003, Journal of cosmetic dermatology.

[276]  H O Handwerker,et al.  Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. , 2003, Journal of neurophysiology.

[277]  J. Saurat,et al.  International Consensus Conference on Atopic Dermatitis II (ICCAD II * ): clinical update and current treatment strategies , 2003, The British journal of dermatology.

[278]  H. Kilbinger,et al.  Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. , 2003, Life sciences.

[279]  Mellar P. Davis,et al.  Mirtazapine for pruritus. , 2003, Journal of pain and symptom management.

[280]  A. Naukkarinen,et al.  Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema , 2003, Archives of Dermatological Research.

[281]  T. Luger.  Neuromediators--a crucial component of the skin immune system. , 2002, Journal of dermatological science.

[282]  P. Sandroni.  Central neuropathic itch: a new treatment option? , 2002, Neurology.

[283]  N. Wade,et al.  The Neuroscience of Helmholtz and the Theories of Johannes Müller , 2002, Journal of the history of the neurosciences.

[284]  J. Berth-Jones,et al.  Azathioprine in severe adult atopic dermatitis: a double‐blind, placebo‐controlled, crossover trial , 2002, The British journal of dermatology.

[285]  T. Diepgen.  Long‐term treatment with cetirizine of infants with atopic dermatitis: A multi‐country, double‐blind, randomized, placebo‐controlled trial (the ETAC™ trial) over 18 months , 2002 .

[286]  G. Yosipovitch,et al.  Clinical characteristics of pruritus in chronic idiopathic urticaria , 2002, The British journal of dermatology.

[287]  A. Wollenberg,et al.  Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. , 2002, Current opinion in investigational drugs.

[288]  P. Spuls,et al.  Low Systemic Exposure after Repeated Topical Application of Pimecrolimus (Elidel®, SD Z ASM 981) in Patients with Atopic Dermatitis , 2002, Dermatology.

[289]  J. Ring,et al.  Topical Steroids under Wet-Wrap Dressings in Atopic Dermatitis – A Vehicle-Controlled Trial , 2002, Dermatology.

[290]  B. Minke,et al.  TRP channel proteins and signal transduction. , 2002, Physiological reviews.

[291]  D. Banville,et al.  Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs , 2002, Nature Neuroscience.

[292]  P. Mulder,et al.  Treatment of Refractory Atopic Dermatitis Using ‘Wet-Wrap’ Dressings and Diluted Corticosteroids: Results of Standardized Treatment in both Children and Adults , 2002, Dermatology.

[293]  A. Slominski,et al.  Alternative splicing of CRH‐R1 receptors in human and mouse skin: identification of new variants and their differential expression , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[294]  Luting Xu,et al.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. , 2001, The Journal of investigative dermatology.

[295]  David J. Anderson,et al.  A Diverse Family of GPCRs Expressed in Specific Subsets of Nociceptive Sensory Neurons , 2001, Cell.

[296]  H. Chan,et al.  The Effectiveness of Wet Wrap Dressings Using 0.1% Mometasone Furoate and 0.005% Fluticasone Proprionate Ointments in the Treatment of Moderate to Severe Atopic Dermatitis in Children , 2001, Pediatric dermatology.

[297]  B. Diffey,et al.  Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial , 2001, The Lancet.

[298]  M. Fishbein,et al.  Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. , 2001, Cardiovascular research.

[299]  A. Knulst,et al.  SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis , 2001, The British journal of dermatology.

[300]  S. Ständer,et al.  Treatment of prurigo nodularis with topical capsaicin. , 2001, Journal of the American Academy of Dermatology.

[301]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.

[302]  A. Wolkerstorfer,et al.  Efficacy and safety of wet‐wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution , 2000, The British journal of dermatology.

[303]  M. Koltzenburg,et al.  Increase in NGF content and nerve fiber sprouting in human allergic contact eczema , 2000, Cell and Tissue Research.

[304]  K. Neuber,et al.  Treatment of atopic eczema with oral mycophenolate mofetil , 2000, The British journal of dermatology.

[305]  F. McGlone,et al.  Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study , 2000, The British journal of dermatology.

[306]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[307]  H. Maibach,et al.  Strontium Nitrate Decreased Histamine-Induced Itch Magnitude and Duration in Man , 2000, Dermatology.

[308]  K. Kawashima,et al.  Extraneuronal cholinergic system in lymphocytes. , 2000, Pharmacology & therapeutics.

[309]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[310]  H. Zhai,et al.  Strontium nitrate suppresses chemically‐induced sensory irritation in humans , 2000, Contact dermatitis.

[311]  A. Finlay,et al.  Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy , 2000, The British journal of dermatology.

[312]  J. Chambers,et al.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) , 2000, British journal of pharmacology.

[313]  H. Hönigsmann,et al.  Half‐side comparison study on the efficacy of 8‐methoxypsoralen bath‐PUVA versus narrow‐band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis , 2000, The British journal of dermatology.

[314]  P. Altmeyer,et al.  Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. , 1999, Journal of the American Academy of Dermatology.

[315]  G. Hahn,et al.  Strontium is a potent and selective inhibitor of sensory irritation. , 1999, Dermatologic Surgery.

[316]  M. Hide,et al.  Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro , 1999, Archives of Dermatological Research.

[317]  S. Artavanis-Tsakonas,et al.  Notch signaling: cell fate control and signal integration in development. , 1999, Science.

[318]  H. Maibach,et al.  Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. , 1999, Acta dermato-venereologica.

[319]  O. Hornstein,et al.  Recent Studies of Cutaneous Nociception in Atopic and Non‐Atopic Subjects , 1999, The Journal of dermatology.

[320]  P. Orn.  [A currently developed method of measurement. A discovery of specific nerve fibers explains the way of itching through the body]. , 1998, Lakartidningen.

[321]  L. Hawkley,et al.  Autonomic, Neuroendocrine, and Immune Responses to Psychological Stress: The Reactivity Hypothesis a , 1998, Annals of the New York Academy of Sciences.

[322]  M. Mihara,et al.  Cutaneous nerves in atopic dermatitis , 1998, Virchows Archiv.

[323]  Stephen P. Hunt,et al.  Altered nociception, analgesia and aggression in mice lacking the receptor for substance P , 1998, Nature.

[324]  Z. Pan.  -Opposing actions of the ?-opioid receptor , 1998 .

[325]  M. Tharp,et al.  Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis. , 1998, International journal of dermatology.

[326]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[327]  Hermann O. Handwerker,et al.  Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.

[328]  P. Elias,et al.  Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. , 1997, Journal of the American Academy of Dermatology.

[329]  M. Green,et al.  The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations , 1997, The British journal of dermatology.

[330]  H. Maibach,et al.  Effect of topical pramoxine on experimentally induced pruritus in humans. , 1997, Journal of the American Academy of Dermatology.

[331]  A. Lucky,et al.  Use of an Emollient As a Steroid‐Sparing Agent in the Treatment of Mild to Moderate Atopic Dermatitis in Children , 1997, Pediatric dermatology.

[332]  M. Lóden.  Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream , 1997, Contact dermatitis.

[333]  S. Eichmüller,et al.  A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle – dependent changes in mast cell – nerve fiber contacts in murine skin , 1997, Archives of Dermatological Research.

[334]  K. Danno,et al.  Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis , 1997, Archives of Dermatological Research.

[335]  S. Stahl,et al.  Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects , 1997, Pharmacotherapy.

[336]  W. Henderson,et al.  Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. , 1996, The Journal of investigative dermatology.

[337]  E. Minshall,et al.  In vivo expression of IL-12 and IL-13 in atopic dermatitis. , 1996, The Journal of allergy and clinical immunology.

[338]  G. Fischer.  Compliance problems in paediatric atopic eczema , 1996, The Australasian journal of dermatology.

[339]  A. Ehlers,et al.  Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. , 1995, Journal of consulting and clinical psychology.

[340]  Z. Wiesenfeld‐Hallin,et al.  Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[341]  J. Wallengren,et al.  Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. , 1995, Journal of the American Academy of Dermatology.

[342]  P. Norén.  Habit reversal: a turning point in the treatment of atopic dermatitis , 1995, Clinical and experimental dermatology.

[343]  H. Degreef,et al.  Atopic dermatitis: triggering factors. , 1994, Journal of the American Academy of Dermatology.

[344]  Q. Hamid,et al.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.

[345]  S. Grabbe,et al.  Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide , 1993, Nature.

[346]  T. Mattila,et al.  Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. , 1993, Annals of allergy.

[347]  J. Polak,et al.  Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis , 1992, The British journal of dermatology.

[348]  A. Dray.  Neuropharmacological mechanisms of capsaicin and related substances. , 1992, Biochemical pharmacology.

[349]  E. Benarroch,et al.  The acetylcholine‐induced flare response in evaluation of small fiber dysfunction , 1991, Annals of neurology.

[350]  M Kawashima,et al.  Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? , 1991, The Journal of investigative dermatology.

[351]  P. Nathan.  Touch and surgical division of the anterior quadrant of the spinal cord. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[352]  A. Scheynius,et al.  Antipruritic effect of oral cyclosporin A in atopic dermatitis. , 1990, Acta dermato-venereologica.

[353]  S. Batra.  Influence of chronic oestrogen treatment on the density of muscarinic cholinergic receptors and calcium channels in the rabbit uterus. , 1990, The Journal of endocrinology.

[354]  L. Melin,et al.  The effect of combined topical steroids and habit‐reversal treatment in patients with atopic dermatitis , 1989, The British journal of dermatology.

[355]  O. Larkö,et al.  UVB phototherapy of atopic dermatitis , 1988, The British journal of dermatology.

[356]  A. Chang,et al.  Interleukin 2 and psoriasis. , 1988, Archives of dermatology.

[357]  R. Marks,et al.  Relief of experimentally induced pruritus with a novel eutectic mixture of local anaesthetic agents , 1988, The British journal of dermatology.

[358]  S. Rosenberg,et al.  Dermatologic changes associated with interleukin 2 administration. , 1987, JAMA.

[359]  H. Yardley.  Epidermal lipids , 1987, International journal of cosmetic science.

[360]  L. Melin,et al.  Behavioural treatment of scratching in patients with atopic dermatitis , 1986, The British journal of dermatology.

[361]  P. Wertz,et al.  Ceramides of pig epidermis: structure determination. , 1983, Journal of lipid research.

[362]  R. Eady,et al.  Vascular responses of human skin to injection of substance P and mechanism of action. , 1983, European journal of pharmacology.

[363]  P. Elias,et al.  Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier. , 1982, The Journal of investigative dermatology.

[364]  B. Fjellner,et al.  Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. , 1981, Acta dermato-venereologica.

[365]  T. Hökfelt,et al.  Flare and itch induced by substance P in human skin. , 1978, The Journal of investigative dermatology.

[366]  Roth Hl,et al.  Hydrocortisone valerate. Double-blind comparison with two other topical steroids. , 1978 .

[367]  N H Azrin,et al.  Habit-reversal: a method of eliminating nervous habits and tics. , 1973, Behaviour research and therapy.

[368]  W. Burckhardt.  [Therapy of pruritus]. , 1971, Minerva medica.

[369]  J. Szolcsányi,et al.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. , 1967, British journal of pharmacology and chemotherapy.

[370]  E. Benditt,et al.  Studies of the mechanism of acute vascular reactions to injury. I. The relationship of mast cells and histamine to the production of edema by ovomucoid in rats. , 1955, A.M.A. archives of pathology.

[371]  W. Sweet,et al.  Anterolateral cordotomy: results, complications and causes of failure. , 1950, Brain : a journal of neurology.

[372]  B. Melnik.  The potential role of impaired Notch signalling in atopic dermatitis. , 2015, Acta dermato-venereologica.

[373]  R. Thurmond,et al.  The Histamine H 4 Receptor Antagonist , JNJ 39758979 , Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects , 2014 .

[374]  S. Ziegler,et al.  The biology of thymic stromal lymphopoietin (TSLP). , 2013, Advances in pharmacology.

[375]  M. Schmelz,et al.  NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin. , 2013, The Journal of investigative dermatology.

[376]  D. Leung.  New insights into atopic dermatitis: role of skin barrier and immune dysregulation. , 2013, Allergology international : official journal of the Japanese Society of Allergology.

[377]  D. Massi,et al.  Notch signaling and the developing skin epidermis. , 2012, Advances in experimental medicine and biology.

[378]  Sang-Mo Kwon,et al.  The molecular basis of Notch signaling: a brief overview. , 2012, Advances in experimental medicine and biology.

[379]  M. Denda,et al.  Roles of transient receptor potential proteins (TRPs) in epidermal keratinocytes. , 2011, Advances in experimental medicine and biology.

[380]  B. Berman.  The Histamine H4 Receptor Mediates Inflammation and Pruritus in Th2-Dependent Dermal Inflammation , 2011 .

[381]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[382]  A. Enk,et al.  Successful treatment of therapy-resistant pruritus in lichen amyloidosis with menthol. , 2009, Acta dermato-venereologica.

[383]  E. Weisshaar,et al.  Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. , 2009, Acta dermato-venereologica.

[384]  F. Kraaimaat,et al.  Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. , 2009, Acta dermato-venereologica.

[385]  P. Heinrich,et al.  IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma. , 2009, The Journal of investigative dermatology.

[386]  Z. Draelos.  Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. , 2008, Current medical research and opinion.

[387]  A. Remitz,et al.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. , 2007, Acta dermato-venereologica.

[388]  K. Yasui,et al.  A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. , 2007, Allergology international : official journal of the Japanese Society of Allergology.

[389]  T. Holland-Letz,et al.  Electrical ear acupuncture reduces histamine-induced itch (alloknesis). , 2006, Acta dermato-venereologica.

[390]  I. H. Engels,et al.  Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. , 2005, The Journal of investigative dermatology.

[391]  J. Szepietowski,et al.  Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. , 2005, Acta dermatovenerologica Croatica : ADC.

[392]  Y. Mosaad,et al.  IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity. , 2004, The Egyptian journal of immunology.

[393]  R. LaMotte,et al.  Comparison of responses of primate spinothalamic tract neurons to pruritic and algogenic stimuli. , 2004, Journal of neurophysiology.

[394]  A. Scheynius,et al.  Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects , 2004, Archives of Dermatological Research.

[395]  F. Sundler,et al.  Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres. , 2004, Acta dermato-venereologica.

[396]  W. Wohlrab,et al.  Quantitative evaluation of urea in stratum corneum of human skin , 2004, Archives of Dermatological Research.

[397]  H. Nagase,et al.  Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. , 2003, European journal of pharmacology.

[398]  J. Szepietowski,et al.  Itch: scratching more than the surface. , 2003, QJM : monthly journal of the Association of Physicians.

[399]  M. Lóden.  Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders , 2003, American journal of clinical dermatology.

[400]  D. Julius,et al.  The vanilloid receptor: a molecular gateway to the pain pathway. , 2001, Annual review of neuroscience.

[401]  A. Craig,et al.  Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch , 2001, Nature Neuroscience.

[402]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. , 2001, Experimental dermatology.

[403]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[404]  T. Agner,et al.  Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. , 1999, Acta dermato-venereologica.

[405]  M. Mihara,et al.  Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. , 1998, Virchows Archiv : an international journal of pathology.

[406]  H. Maibach,et al.  Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. , 1998, The Journal of investigative dermatology.

[407]  Z. Pan.  mu-Opposing actions of the kappa-opioid receptor. , 1998, Trends in pharmacological sciences.

[408]  P. Wertz,et al.  Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. , 1998, Acta dermato-venereologica.

[409]  S. Hunt,et al.  Altered nociception, analgesia, and aggression in mice lacking the substance P receptor , 1998 .

[410]  G. Freitag,et al.  Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. , 1997, Current medical research and opinion.

[411]  J. Warner.  Early treatment of the atopic child. , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[412]  D. Tarng,et al.  Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. , 1996, Nephron.

[413]  H. Korting,et al.  The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers. , 1995, Dermatology.

[414]  A. Azon,et al.  Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. , 1992, Acta dermato-venereologica.

[415]  Y. Okayama,et al.  Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. , 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[416]  R. Bergström,et al.  Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. , 1991, Acta dermato-venereologica.

[417]  O. Larkö,et al.  Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. , 1990, Journal of the American Academy of Dermatology.

[418]  R. Bergström,et al.  Evaluation of a new method of assessing pruritus and antipruritic drugs. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[419]  L. Solomon,et al.  Effect of acupuncture on experimentally induced itch. , 1984, Acta dermato-venereologica.

[420]  Solomon Lm,et al.  Effect of acupuncture on experimentally induced itch. , 1984, Acta dermato-venereologica.

[421]  T. Ayllon,et al.  The behavioral treatment of neurodermatitis through habit-reversal. , 1981, Behaviour research and therapy.

[422]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.

[423]  R. Kaplan,et al.  Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. , 1978, Archives of dermatology.

[424]  H. L. Roth,et al.  Hydrocortisone valerate. Double-blind comparison with two other topical steroids. , 1978, Cutis.